Lupkynis Offers New Hope for Adults Battling Lupus Nephritis
Lupkynis: Uses, Side Effects, Dosage, How to Take, Cost, More
Lupkynis: Uses, Side Effects, Dosage, How to Take, Cost, More
2025-06-06T10:10:45+00:00
immunesystem, lupus, home-and-garden, healthy-cooking, relationships, budget-travel
Lupkynis, a prescription drug produced by AbbVie, has been approved for treating active lupus nephritis in adults. The condition causes the immune system to attack the kidneys, leading to inflammation and potential damage. This medication is now available as an oral capsule under the brand name, with no generic alternative currently on the market.
Lupkynis contains the active ingredient voclosporin, which belongs to a class of drugs known as calcineurin-inhibitor immunosuppressants. It works by blocking a protein called calcineurin, reducing immune system activity to ease lupus nephritis symptoms. Doctors recommend a starting dose of 23.7 mg twice daily, used alongside other immunosuppressive treatments.
Lupkynis offers a targeted treatment option for those with active lupus nephritis. Its use requires careful monitoring due to potential side effects, including serious infections and kidney-related issues. The drug’s approval provides a new approach for managing this autoimmune condition in adult patients.
